Healthcare
KKR to invest $200m in Indian drug maker Gland Pharma
KKR has agreed to buy a minority stake in Gland Pharma, an Indian injectable drugs manufacturer, for approximately $200 million. The investment facilitates the exit of Invascent Capital's Evolvence India Life Sciences Fund (EILSF).
PE-backed China Cinda to raise $2.5b in Hong Kong IPO - report
PE-backed China Cinda Asset Management Corp, one of four groups set up to absorb non-performing loans (NPLs) from the country’s Big Four state-owned banks, is expected to raise up to $2.5 billion in its Hong Kong IPO.
Temasek, Greenwoods back Phoenix Healthcare IPO
Temasek Holdings and Shanghai-based Greenwoods Investment have made a pre-IPO investment in Phoenix Healthcare Group, picking up a 10% stake in the company for RMB165 million ($26.8 million).
Advent adds to China operating partner program
Advent International has appointed healthcare industry veteran Lincoln Chee to its operating partner program in China. He will advise the private equity firm in identifying investment opportunities in the space and in generating value in portfolio companies....
CNEI invests $25.4m in Chinese drug developer
China New Enterprise Investment (CNEI) has acquired a 17% stake in Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ) for $25.4 million, becoming the second-largest shareholder in the Shanghai based bio-pharmaceutical firm.
Darby exits India's Symbiotec Pharmalab, Actis ups stake
Darby Private Equity, the PE arm of Franklin Templeton Investments, has exited its investment in Symbiotec Pharmalab to Actis. Financial terms were not disclosed.
Sequoia leads $16m investment in Cloudnine hospital chain
Sequoia Capital has led INR1 billion ($16.3 million) investment into Bangalore-based infant and maternity care hospital chain Cloudnine. Existing investor Matrix Partners also participated in the round.
KKR invests $89m in Apollo Hospitals' parent
KKR has made an INR5.5 billion ($89.74 million) investment in PCR Investments, the holding company of India’s Apollo Hospitals group.
Qiming invests in traditional Chinese medicine business
Qiming Venture Partners has committed a Series A round of funding to Jun He Tang, a traditional Chinese medicine business. Financial terms were not disclosed.
Tata Capital buys stakes in Tata Sky, Mitra Biotech
Tata Capital’s offshore Tata Opportunities Fund (TOF) has acquired a 5% stake in direct-to-home (DTH) TV provider Tata Sky, while VC fund Tata Capital Innovations has backed cancer care company Mitra Biotech.
Actis invests $48m in Indian pharma company
Actis has invested $48 million for a significant minority stake in Symbiotec Pharmalab, an active pharmaceutical ingredients (API) manufacturer.
Japan's Astellas Pharma leads US-based Mitokyne $45m Series A round
Astellas Pharma, a Tokyo-listed pharmaceutical firm, has led a $45 million Series A round of investment in US biotech start-up Mitokyne, alongside MPM Capital and Longwood Founders Fund.
Quadrant exits Summerset, buys Estia Health
Quadrant Private Equity has fully exited New Zealand retirement village operator Summerset via the public market, generating an estimated return multiple of more than 3.7x. In the same week, it acquired a majority stake in Australian aged-care operator...
IDFC Alternatives invests $20m in Medi Assist
IDFC Alternatives has committed INR1.25 billion ($20.39 million) to Medi Assist, a Bangalore-based health benefits manager.
KKR to invest about $150 million in India's Gland Pharma – report
KKR is reported to be in the process of buying around 30% of Gland Pharma, an active pharmaceutical ingredients and injectable drugs manufacturer, for $150 million.
Singapore's DCP leads $20m Series B for Amaranth Medical
DCP Management has led the $20 million Series B round of funding for Amaranth Medical, a medical device manufacturer. Existing investors Bio*One Capital, Charter Life Sciences and Phillip Capital, as well as new entrant Venstar Capital, also participated....
Panasonic unit gets KKR cure
KKR's acquisition of Panasonic Healthcare marks a return to form for the firm after its earlier efforts to acquire Japanese chipmaker Renesas were frustrated by the government-backed Innovation Network Corporation of Japan (INCJ). The deal had raised...
VC-backed Value HR sees shares double after $8.5m Japan IPO
VC-backed Value HR, a Japanese human resources benefits service provider, saw its stock more than double in value to JPY4035 ($41.5) on its trading debut in Tokyo on Friday.
Abraaj exits Philippines hospital DMMC
The Abraaj Group has made a full exit from Daniel O. Mercado Medical Center (DMMC), a tertiary care hospital based in the Philippines. The exit is said to have been through a buy-back arrangement with the Mercado family.
SMRJ, Daiichi Sankyo, Mitsubishi UFJ launch $10m pharma fund
The Organization for Small & Medium Enterprises and Regional Innovation Japan (SMRJ), pharmaceutical firm Daiichi Sankyo and Mitsubishi UFJ Capital are together launching a new JPY1 billion ($10 million) fund to invest in pharmaceutical start-ups working...
Archer Capital revives interest in NZ's Abano Healthcare
Archer Capital obtained a five-month standstill agreement with shareholders of New Zealand's Abano Healthcare, potentially allowing time for a new takeover bid to come together after its latest effort was rejected earlier this week.
Warburg Pincus invests in China health center Amcare
Warburg Pincus has invested in Beijing-based Amcare Women's & Children's Hospital. The transaction size was not disclosed.
KKR considers teaming with Japan state fund for Panasonic unit - report
KKR may partner with a Japanese state-backed investment fund in a bid to secure a stake in Panasonic's healthcare unit.
WuXi PharmaTech-backed Foundation Medicine sets terms for $75m IPO
US cancer diagnostics firm Foundation Medicine, which counts the corporate venture fund of Shanghai-headquarted WuXi PharmaTech among its backers, has announced the terms for its US IPO.